Literature DB >> 9584200

p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes.

P B Dallas1, I W Cheney, D W Liao, V Bowrin, W Byam, S Pacchione, R Kobayashi, P Yaciuk, E Moran.   

Abstract

p300 and the closely related CREB binding protein (CBP) are transcriptional adaptors that are present in intracellular complexes with TATA binding protein (TBP) and bind to upstream activators including p53 and nuclear hormone receptors. They have intrinsic and associated histone acetyltransferase activity, suggesting that chromatin modification is an essential part of their role in regulating transcription. Detailed characterization of a panel of antibodies raised against p300/CBP has revealed the existence of a 270-kDa cellular protein, p270, distinct from p300 and CBP but sharing at least two independent epitopes with p300. The subset of p300/CBP-derived antibodies that cross-reacts with p270 consistently coprecipitates a series a cellular proteins with relative molecular masses ranging from 44 to 190 kDa. Purification and analysis of various proteins in this group reveals that they are components of the human SWI/SNF complex and that p270 is an integral member of this complex.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9584200      PMCID: PMC108941          DOI: 10.1128/MCB.18.6.3596

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  Cellular targets for transformation by the adenovirus E1A proteins.

Authors:  P Whyte; N M Williamson; E Harlow
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

3.  Analysis with specific polyclonal antiserum indicates that the E1A-associated 300-kDa product is a stable nuclear phosphoprotein that undergoes cell cycle phase-specific modification.

Authors:  P Yaciuk; E Moran
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

4.  Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5.

Authors:  C Egan; T N Jelsma; J A Howe; S T Bayley; B Ferguson; P E Branton
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

5.  CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein.

Authors:  D M Scolnick; N H Chehab; E S Stavridi; M C Lien; L Caruso; E Moran; S L Berger; T D Halazonetis
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701

6.  Analysis of E1A-mediated growth regulation functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity.

Authors:  R W Stein; M Corrigan; P Yaciuk; J Whelan; E Moran
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

7.  Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis.

Authors:  J A Howe; J S Mymryk; C Egan; P E Branton; S T Bayley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

8.  Mutants of yeast defective in sucrose utilization.

Authors:  M Carlson; B C Osmond; D Botstein
Journal:  Genetics       Date:  1981-05       Impact factor: 4.562

9.  Functional interdependence of the yeast SNF2, SNF5, and SNF6 proteins in transcriptional activation.

Authors:  B C Laurent; M A Treitel; M Carlson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

10.  Molecular analysis of SNF2 and SNF5, genes required for expression of glucose-repressible genes in Saccharomyces cerevisiae.

Authors:  E Abrams; L Neigeborn; M Carlson
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

View more
  31 in total

1.  The human SWI-SNF complex protein p270 is an ARID family member with non-sequence-specific DNA binding activity.

Authors:  P B Dallas; S Pacchione; D Wilsker; V Bowrin; R Kobayashi; E Moran
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control.

Authors:  Norman G Nagl; Xiaomei Wang; Antonia Patsialou; Michael Van Scoy; Elizabeth Moran
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

3.  Activating signal cointegrator 1, a novel transcription coactivator of nuclear receptors, and its cytosolic localization under conditions of serum deprivation.

Authors:  H J Kim; J Y Yi; H S Sung; D D Moore; B H Jhun; Y C Lee; J W Lee
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

4.  Mammalian SWI-SNF complexes contribute to activation of the hsp70 gene.

Authors:  I L de La Serna; K A Carlson; D A Hill; C J Guidi; R O Stephenson; S Sif; R E Kingston; A N Imbalzano
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

Review 5.  Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.

Authors:  A R M Ruhul Amin; Phillip A Karpowicz; Thomas E Carey; Jack Arbiser; Rita Nahta; Zhuo G Chen; Jin-Tang Dong; Omer Kucuk; Gazala N Khan; Gloria S Huang; Shijun Mi; Ho-Young Lee; Joerg Reichrath; Kanya Honoki; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; W Nicol Keith; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Hiromasa Fujii; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang; Alan Bilsland; Dong M Shin
Journal:  Semin Cancer Biol       Date:  2015-03-06       Impact factor: 15.707

6.  Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein.

Authors:  Adam F L Hurlstone; Ivan A Olave; Nick Barker; Mascha van Noort; Hans Clevers
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

Review 7.  A rationale to target the SWI/SNF complex for cancer therapy.

Authors:  Anja F Hohmann; Christopher R Vakoc
Journal:  Trends Genet       Date:  2014-06-03       Impact factor: 11.639

8.  Differential targeting of two distinct SWI/SNF-related Drosophila chromatin-remodeling complexes.

Authors:  Lisette Mohrmann; Karin Langenberg; Jeroen Krijgsveld; Arnoud J Kal; Albert J R Heck; C Peter Verrijzer
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

9.  Highly parallel identification of essential genes in cancer cells.

Authors:  Biao Luo; Hiu Wing Cheung; Aravind Subramanian; Tanaz Sharifnia; Michael Okamoto; Xiaoping Yang; Greg Hinkle; Jesse S Boehm; Rameen Beroukhim; Barbara A Weir; Craig Mermel; David A Barbie; Tarif Awad; Xiaochuan Zhou; Tuyen Nguyen; Bruno Piqani; Cheng Li; Todd R Golub; Matthew Meyerson; Nir Hacohen; William C Hahn; Eric S Lander; David M Sabatini; David E Root
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-17       Impact factor: 11.205

Review 10.  ARID1A mutations in cancer: another epigenetic tumor suppressor?

Authors:  Jennifer N Wu; Charles W M Roberts
Journal:  Cancer Discov       Date:  2012-12-03       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.